Award

Novel liver-mediated mechanisms in hypertension and cardiac dysfunction

Description: Cardiovascular disease (CVD) is a significant complication of non-alcoholic fatty liver disease (NAFLD). Despite the significant morbidity associated with NAFLD-induced CVD, the link between NAFLD and CVD is not known. This proposal will determine the role of hepatic steatosis independent of obesity, type II diabetes or dyslipidemia to the development of NAFLD-induced CVD.
Funding type: research
Funder scheme: R01
Start date: 2025-05-15
End date: 2029-02-28
Investigator: TERRY D HINDS (lead)
Institutions: University of Mississippi, UNIVERSITY OF MISSISSIPPI MED CTR
Subfield: Hepatology
Field: Medicine
Funded outputs count: 22
Funder award ID: R01HL174521
OpenAlex ID: G9000900038
2026 · Michael I. Adenawoola, Alan J. Mouton, et al. · International Journal of Molecular Sciences
2026 · Lucy C. Taylor, Michael I. Adenawoola, et al. · Current Hypertension Reports
2026 · Sally N. Pauss, Zachary A. Kipp, et al. · Frontiers in Cellular Neuroscience
2026 · Olufunto O. Badmus, Landon D. Parrow, et al. · International Journal of Molecular Sciences
2026 · Genesee J. Martinez, David E. Stec, et al. · Trends in Endocrinology and Metabolism · 4
2026 · Jayela M Davis, Annointing Ogbewekon, et al. · Gastroenterology report
2025 · Wang-Hsin Lee, Zachary A. Kipp, et al. · Clinical Science · 56
2025 · Gertrude Arthur, Michael I. Adenawoola, et al. · Kidney360 · 4
2024 · Lucy C. Taylor, Gertrude Arthur, et al. · International Journal of Translational Medicine · 17